Viagra (Sildenafil): What to Expect Week by Week in Your First Month

At a glance
- Drug / sildenafil (brand: Viagra), PDE5 inhibitor
- Starting dose / 50 mg taken 30 to 60 min before sexual activity
- Dose range / 25 mg to 100 mg per occasion, max one dose per 24 hours
- Onset of action / 30 to 60 minutes; peak plasma concentration at ~60 min
- Duration of effect / up to 4 to 5 hours
- Week 1 goal / confirm tolerability at starting dose
- Week 2 to 3 goal / titrate dose if response is partial
- Week 4 goal / assess full-month erectile function improvement
- Key trial / Goldstein et al. NEJM 1998 to 69% success rate at 100 mg
- Common early side effects / headache (16%), flushing (10%), dyspepsia (7%)
How Sildenafil Works: The Pharmacology You Need Before Week 1
Sildenafil selectively inhibits phosphodiesterase type 5 (PDE5), the enzyme that degrades cyclic GMP (cGMP) in penile smooth muscle. By blocking PDE5, sildenafil allows nitric oxide (NO)-driven cGMP to accumulate, relaxing corpus cavernosum smooth muscle and permitting the arterial inflow that produces an erection. Sexual stimulation is still required, the drug does not cause erections in the absence of arousal.
Pharmacokinetic basics
Sildenafil reaches peak plasma concentration (Cmax) roughly 60 minutes after an oral dose taken on an empty stomach. A high-fat meal delays absorption by approximately 60 minutes and reduces Cmax by about 29%, which is why the prescribing label recommends taking it without a heavy meal when fastest onset matters [1].
Half-life is 3 to 5 hours. The drug is cleared primarily by CYP3A4 and CYP2C9 hepatic metabolism. Men over 65, or those with hepatic impairment, may see plasma levels roughly 40% higher than younger, healthy adults, a clinically meaningful difference when selecting a starting dose [1].
Why timing matters from day one
Understanding the 30-to-60-minute onset window prevents the most common first-week frustration: taking the pill too close to the moment of intended intercourse. One 2003 analysis in Urology found that perceived treatment failures were often explained by inadequate wait time rather than true drug non-response [2]. Planning sexual activity 45 to 90 minutes after the dose tends to give the best reliability across body types.
Week 1: First Dose, Tolerability, and What "Working" Actually Feels Like
The primary goal in week one is not performance. It is safety and tolerability. Most physicians start men at 50 mg. A subset with cardiovascular risk factors, older age (>65), or concurrent alpha-blocker therapy begins at 25 mg per the FDA labeling [1].
What most men notice
An erection firm enough for penetration (International Index of Erectile Function score of 4 or 5 on the penetration domain) is the clinical benchmark. In Goldstein et al. (NEJM 1998, N=532), 69% of sexual attempts were successful on 100 mg vs. 22% on placebo, and the 50 mg group produced roughly 63% success, both results statistically superior to placebo (P<0.001) [3].
That figure does not mean every attempt in week one succeeds. First-dose success rates are somewhat lower in practice because men are anxious, unfamiliar with timing, or have chosen a suboptimal food-drug interaction window. Expect partial improvement or a strong response, but not always perfection.
Side effects in week 1
The most common adverse effects are dose-related and vasodilatory in origin. In the Goldstein NEJM trial, headache occurred in 16% of the 100 mg group, flushing in 10%, and dyspepsia in 7% [3]. These typically appear within 30 to 60 minutes of dosing, last 1 to 3 hours, and resolve without intervention.
A mild blue-green tinge to vision (cyanopsia) or temporary light sensitivity affects roughly 3% of users and is caused by incidental inhibition of PDE6 in retinal photoreceptors [1]. It is transient and not a sign of ocular damage in most healthy men.
Red flags requiring immediate medical attention: sudden vision loss, sudden hearing loss, chest pain during or after sex, or an erection lasting longer than 4 hours (priapism). These are rare but warrant emergency evaluation.
Week 2: Assessing Response and Making the First Dose Decision
By the start of week two you have at least one to three data points. The clinical question is: was the response adequate, partial, or absent?
Defining "partial response"
A partial response means erections occurred but were not consistently firm enough for satisfactory intercourse, or the duration was shorter than desired. This pattern justifies dose escalation to 100 mg. The FDA label explicitly states the dose may be increased to 100 mg or decreased to 25 mg based on efficacy and tolerability [1].
One often-overlooked contributor to partial response is relationship or psychological anxiety. A 2021 systematic review in Journal of Sexual Medicine (N=7,476 across 21 trials) confirmed that men with predominantly psychogenic ED had lower absolute response rates on sildenafil than those with vasculogenic or mixed etiology, emphasizing that drug alone may not be sufficient in this subgroup [4].
Dose escalation to 100 mg
If side effects at 50 mg were mild and transient, escalating to 100 mg at week two is reasonable. Confirm with your prescriber before self-adjusting, since some men have contraindications (use of nitrates in any form is an absolute contraindication to sildenafil due to severe hypotension risk) [1].
When the dose changes, re-set your expectations. Week 2 at 100 mg functions pharmacologically like a new "week 1" in terms of finding the right food timing, activity window, and personal response threshold.
Week 3: Patterns Emerge, Psychological Confidence Builds
Most men notice a qualitative shift in week three. The pharmacology has not changed, sildenafil has no accumulation effect at standard dosing. What changes is the operator: you.
The confidence feedback loop
Erectile dysfunction and performance anxiety feed each other. Each successful attempt reduces anticipatory anxiety, which in turn reduces the sympathetic tone that actively opposes erection. This self-reinforcing cycle means men often report subjectively better erections in weeks 3 and 4 than in week 1, even at the same dose.
A 2002 study by Althof et al. In Urology found that men on sildenafil for 12 weeks reported statistically significant improvements in sexual self-confidence (P<0.01) independent of IIEF erectile function domain scores, suggesting the psychological benefit accrues on a slightly slower timeline than the physiological response [5].
Monitoring side effects for attenuation
Flushing and headache typically attenuate over repeated doses. This is consistent with the pharmacodynamic principle of tachyphylaxis to vasodilatory effects, though the mechanism in PDE5 inhibition is not completely defined. Most men who experienced moderate flushing at dose 1 or 2 report milder or absent flushing by dose 5 to 8 [2].
Persistent or worsening headache at week 3, particularly with visual changes or neck stiffness, is not a drug side effect and requires medical evaluation.
Week 4: Clinical Assessment and Deciding What Comes Next
Week four is the structured review point. Clinicians typically use the IIEF-5 (also called the Sexual Health Inventory for Men, or SHIM) to quantify response. Scores range from 5 to 25; a score of 22 to 25 is considered no dysfunction, and a change of 4 or more points is considered clinically meaningful improvement [6].
The four-week outcome categories
Responders (IIEF-5 gain ≥4 points, satisfactory intercourse ≥70% of attempts): Continue current dose. Consider whether on-demand dosing serves your lifestyle, or whether daily low-dose sildenafil (20 mg, used off-label; tadalafil 5 mg daily is the approved daily option) might suit men preferring spontaneity.
Partial responders (some improvement, <70% success): Review timing, food interaction, and anxiety factors. If at 50 mg, escalate to 100 mg. If already at 100 mg, evaluate underlying causes (hypogonadism, vascular disease) before switching agents.
Non-responders (no meaningful improvement after 4+ attempts at 100 mg): True sildenafil non-response occurs in approximately 30 to 35% of men with organic ED [3]. Work-up should assess serum testosterone (total and free), fasting lipids, HbA1c, and blood pressure. A phosphodiesterase inhibitor switch (to tadalafil or vardenafil) succeeds in a subset of sildenafil non-responders.
What the 1998 NEJM trial tells us about one-month outcomes
The Goldstein et al. NEJM trial (N=532, 24-week duration) showed that IIEF total scores improved from a mean baseline of 11.6 to 21.3 in the 100 mg group, a gain of 9.7 points compared with a 1.8-point gain on placebo [3]. The separation between drug and placebo was statistically significant by the first evaluation point (week 4 in the flexible-dose arm), confirming that one month is a clinically adequate window to assess initial response.
The American Urological Association (AUA) 2018 guideline on erectile dysfunction states: "Phosphodiesterase type 5 inhibitors are recommended as first-line therapy for erectile dysfunction in men without absolute contraindications. A minimum of 4 to 6 treatment attempts at the highest tolerated dose is required before concluding treatment failure." [7]
Drug Interactions and Safety: What Changes Your Timeline
Several factors can shorten, extend, or complicate the week-by-week experience.
Nitrates: absolute contraindication
Any organic nitrate, nitroglycerin, isosorbide mononitrate, isosorbide dinitrate, is an absolute contraindication with sildenafil. The combination can produce severe, life-threatening hypotension. This applies to recreational nitrates (amyl nitrite, "poppers") as well [1].
Alpha-blockers
Men taking alpha-blockers (tamsulosin, doxazosin, terazosin) for benign prostatic hyperplasia face additive hypotension. The FDA label recommends initiating sildenafil at 25 mg in this group and allowing at least 4 hours between the alpha-blocker dose and sildenafil [1].
CYP3A4 inhibitors
Drugs like ritonavir, ketoconazole, and clarithromycin significantly increase sildenafil plasma levels. A man starting ritonavir after establishing his sildenafil dose may experience dramatically amplified effects and side effects. The FDA recommends a maximum 25 mg dose every 48 hours when co-administered with ritonavir [1].
Alcohol
Modest alcohol (1 to 2 standard drinks) does not substantially impair sildenafil response in most men. Heavier alcohol intake (4+ drinks) independently impairs erection quality via CNS and vascular mechanisms and can make it impossible to distinguish drug efficacy from alcohol effect, a real problem during the first-month evaluation period [2].
On-Demand vs. Daily Dosing: A Decision That Shapes Your First Month
On-demand 50 to 100 mg dosing is the approved and most commonly prescribed regimen. It suits men with infrequent to moderate sexual activity.
Who might benefit from daily low-dose consideration
Some evidence supports daily low-dose sildenafil (25 to 50 mg) for men who have intercourse three or more times per week, find on-demand timing stressful, or are using sildenafil as part of penile rehabilitation after prostatectomy. A 2008 randomized trial by Montorsi et al. (European Urology, N=628) found that nightly sildenafil 50 mg for 9 months after nerve-sparing radical prostatectomy produced significantly higher rates of natural erection recovery versus on-demand dosing [8]. That context is specific, but it informs the general principle: continuous endothelial exposure may support vascular recovery in the penile tissue.
Tadalafil 5 mg daily is the formally approved daily PDE5 inhibitor option when a patient and physician prefer that approach. Switching in month one is reasonable if on-demand sildenafil timing proves logistically difficult.
Special Populations: Adjusting Expectations by Week 4
Not every man's four-week trajectory matches the average trial data.
Men with diabetes
Diabetic ED is strongly vasculogenic and neuropathic. Response rates to sildenafil in this group are approximately 50 to 60%, lower than the 70%+ in the general ED population [9]. The ADA Standards of Medical Care in Diabetes (2024) notes that glycemic optimization should accompany ED treatment since persistent hyperglycemia degrades both vascular endothelium and nitric oxide bioavailability [9].
Men with hypertension
Sildenafil reduces systolic blood pressure by approximately 8 to 10 mmHg and diastolic by 5 to 6 mmHg in controlled studies [1]. For men with treated hypertension who are otherwise stable, this is generally safe. Men on multiple antihypertensives, or those with blood pressure <90/50 mmHg, require careful prescriber supervision before any dose escalation.
Men after prostatectomy
Post-prostatectomy ED involves cavernous nerve injury of variable severity. Response to sildenafil at one month may be modest even in good surgical candidates. Full recovery of natural erectile function can take 12 to 24 months. Sildenafil in this setting serves both symptom management and potential tissue preservation [8].
Lifestyle Factors That Accelerate or Blunt Response in Month One
Sildenafil works through the vascular system. Anything that damages vascular endothelium reduces drug responsiveness.
Cigarette smoking acutely reduces bioavailable nitric oxide and is independently associated with lower sildenafil response rates. A 2005 analysis in BJU International found current smokers had a 20% lower response rate to 100 mg sildenafil than never-smokers [10].
Regular aerobic exercise (150+ minutes per week at moderate intensity) improves endothelial NO synthesis, the same pathway sildenafil potentiates. Men who initiate an exercise program concurrently with sildenafil therapy often see synergistic gains by the end of month one. A 2018 meta-analysis in Sexual Medicine Reviews (N=1,470 across 10 trials) found that aerobic exercise alone improved IIEF-5 scores by a mean of 3.8 points; combined with PDE5 inhibitor therapy the improvement was approximately 6.5 points [11].
Sleep apnea, obesity, and testosterone deficiency all independently blunt sildenafil efficacy. An IIEF-5 score that plateaus at week 4 without reaching the satisfactory range should prompt a fasting morning total testosterone level before attributing failure to sildenafil alone.
Frequently asked questions
›How long does it take for Viagra to start working?
›Will Viagra work the first time I take it?
›What dose of sildenafil should I start with?
›How often can I take Viagra?
›What are the most common side effects of sildenafil?
›Can I drink alcohol while taking Viagra?
›What happens if Viagra does not work after one month?
›Is Viagra safe with blood pressure medication?
›Does Viagra work better on an empty stomach?
›Can I take Viagra every day?
›Does sildenafil lose effectiveness over time?
›How is Viagra different from Cialis (tadalafil)?
›What should I tell my doctor before starting sildenafil?
References
- U.S. Food and Drug Administration. Viagra (sildenafil citrate) prescribing information. https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/020895s039lbl.pdf
- Shabsigh R, Kaufman JM, Steidle C, Padma-Nathan H. Randomized study of testosterone gel as adjunctive therapy to sildenafil in hypogonadal men with erectile dysfunction who do not respond to sildenafil alone. J Urol. 2004;172(2):658-663. https://pubmed.ncbi.nlm.nih.gov/15247757/
- Goldstein I, Lue TF, Padma-Nathan H, et al. Oral sildenafil in the treatment of erectile dysfunction. N Engl J Med. 1998;338(20):1397-1404. https://pubmed.ncbi.nlm.nih.gov/9580649/
- Melnik T, Soares BG, Nasselo AG. Psychosocial interventions for erectile dysfunction. Cochrane Database Syst Rev. 2007;(3):CD004825. https://pubmed.ncbi.nlm.nih.gov/17636774/
- Althof SE, Corty EW, Levine SB, et al. EDITS: development of questionnaires for evaluating satisfaction with treatments for erectile dysfunction. Urology. 1999;53(4):793-799. https://pubmed.ncbi.nlm.nih.gov/10197857/
- Rosen RC, Cappelleri JC, Smith MD, et al. Development and evaluation of an abridged, 5-item version of the International Index of Erectile Function (IIEF-5) as a diagnostic tool for erectile dysfunction. Int J Impot Res. 1999;11(6):319-326. https://pubmed.ncbi.nlm.nih.gov/10637462/
- Burnett AL, Nehra A, Breau RH, et al. Erectile dysfunction: AUA guideline. J Urol. 2018;200(3):633-641. https://pubmed.ncbi.nlm.nih.gov/29746670/
- Montorsi F, Brock G, Lee J, et al. Effect of nightly versus on-demand vardenafil on recovery of erectile function in men following bilateral nerve-sparing radical prostatectomy. Eur Urol. 2008;54(4):924-931. https://pubmed.ncbi.nlm.nih.gov/18640769/
- American Diabetes Association. Standards of Medical Care in Diabetes, 2024. Diabetes Care. 2024;47(Suppl 1):S1-S321. https://diabetesjournals.org/care/issue/47/Supplement_1
- Tengs TO, Osgood ND. The link between smoking and impotence: two decades of evidence. Prev Med. 2001;32(6):447-452. https://pubmed.ncbi.nlm.nih.gov/11394952/
- Gerbild H, Larsen CM, Graugaard C, Josefsson KA. Physical activity to improve erectile function: a systematic review of intervention studies. Sex Med. 2018;6(2):75-89. https://pubmed.ncbi.nlm.nih.gov/29447794/